Is MFCAX or JNJ a better dividend investment in 2026?

MFCAX currently yields 13.51% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: MFCAX offers higher current income.

What is the dividend yield difference between MFCAX and JNJ?

MFCAX has a forward dividend yield of 13.51% ($5.02/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 10.15 percentage points.

Home › Compare › MFCAX vs JNJ

MFCAX vs JNJ: Dividend Comparison 2026

MFCAX yields 13.51% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MFCAX wins by $28.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MFCAX

● Live price

13.51%

Share price

$37.12

Annual div

$5.02

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$48.6K

Annual income

$3,126.02

Full MFCAX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — MFCAX vs JNJ

📍 MFCAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MFCAX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MFCAX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MFCAX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MFCAX

Annual income on $10K today (after 15% tax)

$1,148.49/yr

After 10yr DRIP, annual income (after tax)

$2,657.12/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, MFCAX beats the other by $1,953.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MFCAX + JNJ for your $10,000?

MFCAX: 50%JNJ: 50%

100% JNJ50/50100% MFCAX

Portfolio after 10yr

$34.3K

Annual income

$1,976.90/yr

Blended yield

5.76%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MFCAX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MFCAX buys

JNJ buys

No recent congressional trades found for MFCAX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMFCAXJNJ

Forward yield	13.51% ✓	3.36%
Annual dividend / share	$5.02 ✓	$4.96
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$48.6K ✓	$20.0K
Annual income after 10y	$3,126.02 ✓	$827.78
Total dividends collected	$22.1K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: MFCAX vs JNJ ($10,000, DRIP)

Year	MFCAX Portfolio	MFCAX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,051	$1,351.16	$10,676	$355.77	+$1.4K → MFCAX
2	$14,417	$1,521.78	$11,407	$389.39	+$3.0K → MFCAX
3	$17,127	$1,701.38	$12,198	$426.53	+$4.9K → MFCAX
4	$20,215	$1,889.03	$13,056	$467.62	+$7.2K → MFCAX
5	$23,714	$2,083.75	$13,987	$513.12	+$9.7K → MFCAX
6	$27,658	$2,284.49	$14,998	$563.56	+$12.7K → MFCAX
7	$32,084	$2,490.17	$16,098	$619.52	+$16.0K → MFCAX
8	$37,030	$2,699.70	$17,295	$681.69	+$19.7K → MFCAX
9	$42,534	$2,912.00	$18,599	$750.82	+$23.9K → MFCAX
10	$48,638	$3,126.02	$20,022	$827.78	+$28.6K → MFCAX

MFCAX vs JNJ: Complete Analysis 2026

MFCAX — Stock

The Advisor emphasizes stocks which the Investment Adviser believes are undervalued in relation to the business' (or issuer's) long-term earnings power or asset value, or the stock market in general. The advisor intends to invest at least 65% of its total assets in common stocks and equity-related securities (such as convertible debt securities and warrants). It may invest up to 35% of its total assets in debt or fixed income securities, including higher yield, higher risk, lower rated or unrated corporate bonds commonly referred to as "junk bonds."

Full MFCAX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this MFCAX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MFCAX vs SCHD MFCAX vs JEPI MFCAX vs O MFCAX vs KO MFCAX vs MAIN MFCAX vs ABBV MFCAX vs MRK MFCAX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.